SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 1,875.29 |
| Enterprise Value ($M) | 2,040.86 |
| Book Value ($M) | -209.93 |
| Book Value / Share | -0.76 |
| Price / Book | -8.93 |
| NCAV ($M) | -346.46 |
| NCAV / Share | -1.26 |
| Price / NCAV | -5.41 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | 0.16 |
| Return on Assets (ROA) | 0.07 |
| Return on Equity (ROE) | n/a |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 4.17 |
| Current Ratio | 4.54 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 327.66 |
| Assets | 464.20 |
| Liabilities | 674.13 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Vanguard Group Inc | 5.66 | 11.60 | |
| 13G/A | BlackRock, Inc. | 8.30 | 6.13 | |
| 13G/A | State Street Corp | 4.80 | -25.02 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 408,099 | 1,941,296 | 21.02 | |
| 853,331 | 4,646,134 | 18.37 | |
| 582,103 | 3,021,330 | 19.27 | |
| 460,265 | 2,057,480 | 22.37 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| LXEO – Lexeo Therapeutics, Inc. | MDWD – MediWound Ltd. |
| MIRM – Mirum Pharmaceuticals, Inc. | MNOV – MediciNova, Inc. |
| MRNS – Marinus Pharmaceuticals, Inc. |